Evidence map›Paper›PMID 42375627›Full record

ArticleNAM journal2025

GenoITS: Implementation of an Integrated Testing Strategy workflow for genotoxicity using QSAR-based tools.

José Luis Vallés-Pardo, Eva Serrano-Candelas, Addel Goya-Jorge, Salvador Moncho, Mar Crespo, Donna S Macmillan, Rafael Gozalbes

Abstract read
In one paragraph

Article in NAM journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

José Luis Vallés-PardoProtoQSAR S.L., Paterna, (València), Spain.
Eva Serrano-CandelasProtoQSAR S.L., Paterna, (València), Spain.
Addel Goya-JorgeProtoQSAR S.L., Paterna, (València), Spain.
Salvador MonchoProtoQSAR S.L., Paterna, (València), Spain.
Mar CrespoToxiconsultant S.L., Nava, Spain.
Donna S MacmillanHumane Society International, Washington D.C., WA, USA.
Rafael GozalbesProtoQSAR S.L., Paterna, (València), Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To assess the potential impact of chemical substances on human health and the environment, and to ensure the safety of chemicals, the EU's REACH regulation requires registrants of chemicals to undertake a battery of tests to fulfil Standard Information Requirements. These tests raise two main concerns, (1) the economic burden due to the resources needed to perform the tests, both in materials and time invested, and (2) the ethical considerations of using animal testing. For this reason, nowadays the regulatory agencies encourage registrants to minimize the number of experiments performed on animals (3Rs). In this work we have developed an exclusively computational Integrated Testing Strategy to assess the genotoxicity of chemicals. A complete set of data of assays for gene mutation and cytogenotoxicity (in bacteria,

Indexed as

GENOTOXICITYITSNAMsQSAR

Identifiers

PMID42375627
PMCPMC13312421

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.